IMcoMET is a MedTech startup. We have developed a technology - called the M-Duo Technology® - that allows access and control of fluid around cells, called interstitial fluid. This fluid contains many biomarkers that provide detailed information about both the local tissue condition and general health status of an individual. We are integrating our M-Duo Technology® into a set of tools to improve skin cancer diagnostics and skin cancer research to drive personalized medicine and biomedical research forward. Both with the ultimate goal to improve therapy outcomes for skin cancer patients.